JMS Co

JMS Co Capital Intensity

The Capital Intensity Ratio of JMS Co (7702.T) as of Nov 2, 2026 is 126.16 %. In the previous year, Capital Intensity Ratio was 116.75 % — a change of 8.06% (higher).

Capital Intensity

126.16 %

YoY

8.06%

Last updated:

Capital Intensity Ratio of JMS Co is 2026 126.16 % . Capital Intensity Ratio of JMS Co was 2025 116.75 % . It decreases by 8.06% higher compared to the previous year.

The JMS Co Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2019
115.95 JPY
Jan 1, 2020
113.66 JPY
Jan 1, 2021
119.99 JPY
Jan 1, 2022
123.73 JPY
Jan 1, 2023
116.74 JPY
Jan 1, 2024
129.74 JPY
Jan 1, 2025
116.75 JPY
Jan 1, 2026
126.16 JPY
The JMS Co Capital Intensity history
YEARCapital IntensityYoY
126.16 %+8.06%
116.75 %-10.01%
129.74 %+11.14%
116.74 %-5.65%
123.73 %+3.12%
119.99 %+5.57%
113.66 %-1.98%
115.95 %-2.63%
119.08 %+0.76%
118.19 %+4.52%
113.08 %+3.63%
109.12 %+10.43%
98.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JMS Co Stock analysis

What does JMS Co do? JMS Co., Ltd. generates revenue through the manufacture, sale, export, and import of medical devices and pharmaceuticals across its five geographical segments: Japan, Singapore, China, Philippines, and Germany. The company offers a range of products including infusion and nutrition products, dialysis products, surgery products, blood and cell products, and other related items. Key products such as infusion & transfusion sets, syringe pumps, surgical gowns, dialysis kits, peritoneal dialysate, microcatheters, and blood bags are sold to healthcare providers and institutions within these regions. The firm also provides maintenance services and other related services as part of its product portfolio. The company's primary customers are healthcare providers and institutions in Japan, Singapore, China, Philippines, and Germany, where it operates through its five geographical segments. These customers purchase medical equipment and drugs, including specific items like infusion & transfusion sets, dialysis kits, and surgical gowns. The firm's product lines are tailored to meet the needs of hospitals, clinics, and other medical facilities across its operational regions. JMS Co., Ltd. focuses on manufacturing and selling medical equipment and drugs, with a strong emphasis on products such as infusion & transfusion sets, syringe pumps, surgical gowns, and dialysis kits. The company's revenue streams are driven by the sale of these products and the provision of maintenance services. Its geographical segments ensure a diversified market presence, allowing it to serve various healthcare sectors in different countries. JMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JMS Co stock

Capital Intensity Ratio of JMS Co is 126.16 % in 2026.

Capital Intensity Ratio of JMS Co changed from 116.75 % to 126.16 %, representing a 8.06% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio JMS Co since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's JMS Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — JMS Co

All Key Metrics — JMS Co